ArticleFrontiers in pharmacology2024

A retrospective study on the efficacy and safety of Envafolimab, a PD-L1 inhibitor, in the treatment of advanced malignant solid tumors.

Congjun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.